Udayakumar T, Stoyanova R, Shareef M, Mu Z, Philip S, Burnstein K
Mol Cancer Ther. 2016; 15(6):1353-63.
PMID: 26944919
PMC: 4933508.
DOI: 10.1158/1535-7163.MCT-15-0332.
Fichtner I, Zeisig R, Naundorf H, Jungmann S, Arndt D, Asongwe G
Breast Cancer Res Treat. 1994; 32(3):269-79.
PMID: 7865855
DOI: 10.1007/BF00666004.
Girgert R, Schweizer P, Bock I, Narr R, Bruchelt G
J Cancer Res Clin Oncol. 1995; 121(5):262-6.
PMID: 7768962
DOI: 10.1007/BF01209591.
Berdel W
Blut. 1982; 44(2):71-8.
PMID: 7059692
DOI: 10.1007/BF00320092.
Honma Y, Kasukabe T, Okabe-Kado J, Hozumi M, Tsushima S, Nomura H
Cancer Chemother Pharmacol. 1983; 11(2):77-9.
PMID: 6578883
DOI: 10.1007/BF00254249.
Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
Dulisch I, Neumann H, LOHR G, Andreesen R
Blut. 1985; 51(6):393-9.
PMID: 3865693
DOI: 10.1007/BF00320725.
Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.
Berdel W, Von Hoff D, Unger C, Schick H, Fink U, Reichert A
Lipids. 1986; 21(4):301-4.
PMID: 3713449
DOI: 10.1007/BF02536417.
Immunomodulatory and therapeutic properties of alkyl lysophospholipids in mice.
Talmadge J, Schneider M, Lenz B, Phillips H, Long C
Lipids. 1987; 22(11):871-7.
PMID: 3502167
DOI: 10.1007/BF02535547.
In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.
Leder G, Fiebig H, Wallbrecher E, Winterhalter B, LOHR G
Lipids. 1987; 22(11):958-61.
PMID: 3444393
DOI: 10.1007/BF02535564.
Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
Fromm M, Berdel W, Schick H, Fink U, Pahlke W, Bicker U
Lipids. 1987; 22(11):916-8.
PMID: 3444385
DOI: 10.1007/BF02535554.
Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
Danhauser S, Berdel W, Schick H, Fromm M, Reichert A, Fink U
Lipids. 1987; 22(11):911-5.
PMID: 3444384
DOI: 10.1007/BF02535553.
Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.
VOGLER W, Olson A, Okamoto S, Somberg L, Glasser L
Lipids. 1987; 22(11):919-24.
PMID: 3328027
DOI: 10.1007/BF02535555.
Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.
Ngwenya B, Yamamoto N
Cancer Immunol Immunother. 1986; 21(3):174-82.
PMID: 2938735
PMC: 11038332.
DOI: 10.1007/BF00199358.
Activation of macrophages by ether analogues of lysophospholipids.
Yamamoto N, Ngwenya B, SERY T, Pieringer R
Cancer Immunol Immunother. 1987; 25(3):185-92.
PMID: 2824051
PMC: 11038200.
DOI: 10.1007/BF00199146.
Membrane-interactive lipids as experimental anticancer drugs.
Berdel W
Br J Cancer. 1991; 64(2):208-11.
PMID: 1892746
PMC: 1977494.
DOI: 10.1038/bjc.1991.277.
Comparison of selective cytotoxicity of alkyl lysophospholipids.
VOGLER W, Olson A, Okamoto S, Shoji M, Raynor R, Kuo J
Lipids. 1991; 26(12):1418-23.
PMID: 1819744
DOI: 10.1007/BF02536579.